مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Assessing the auditory effects of oral chelation therapy drug Deferasirox in individuals with β‐thalassemia major

Authors : Balwinder S. Tiwana; Ankita Aggarwal; Sanjeev Bhagat

Subjects: auditory; deferasirox; distortion product otoacoustic emissions

Source: World Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 10, Iss 4, Pp 309-314 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

PRT to predict pharmacokinetic profiles as part of a bioequivalence study of the drug deferasirox

Authors : A. V. Suvorova; P. A. Losenkova; Yu. V. Medvedev

Subjects: deferasirox; hplc; pbpk

Source: Разработка и регистрация лекарственных средств, Vol 13, Iss 3, Pp 166-175 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles

Authors : Mahya Mobinikhaledi; Vahid Falahati; Amin Tajerian

Subjects: thalassemia major; deferasirox; liver

Source: Frontiers in Pharmacology, Vol 15 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Deferasirox-induced hyperammonemia and Fanconi syndrome: a case report

Authors : Houfu Zhou; Daoxue Xiong; Yan Feng

Subjects: hyperchloremic acidosis; deferasirox hyperchloremic; metabolic acidosis

Source: Frontiers in Pediatrics, Vol 12 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics

Authors : Belén García-Fariña; Lydia Rink; Virginia Santarini

Subjects: deferasirox; beta thalassemia; toxicity

Source: Frontiers in Pharmacology, Vol 15 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Nanoparticle-Mediated Delivery of Deferasirox: A Promising Strategy Against Invasive Aspergillosis

Authors : Sydney Peppe; Moloud Farrokhi; Evan A. Waite

Subjects: invasive aspergillosis (IA); antifungal resistance; nanoparticles (NPs)

Source: Bioengineering, Vol 11, Iss 11, p 1115 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Deferasirox in Patients with Chronic Kidney Disease: Assessing the Potential Benefits and Challenges

Authors : Nashwan AJ; Yassin MA

Subjects: chronic kidney disease; deferasirox; chelating therapy

Source: Journal of Blood Medicine, Vol Volume 14, Pp 589-594 (2023)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Deferasirox adherence in patients with thalassemia: Exploring the association with patient knowledge and ferritin levels

Authors : Reem Ali Shaker; Fadhil Abduljabbar Rizij; Talib Abduljaleel Jasim

Subjects: Pharmacy and materia medica; RS1-441

Source: Pharmacia, Vol 71, Iss , Pp 1-6 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Switching from Deferasirox Dispersible Tablets to Deferasirox Film-Coated Tablets: Is There an Effect on Ferritin Levels in Children and Adolescents with Transfusion-Dependent Anemia?

Authors : Esra Arslantaş; Ali Ayçiçek; Sibel Akpınar Tekgündüz

Subjects: Pediatrics; RJ1-570

Source: Turkish Archives of Pediatrics, Vol 59, Iss 2, Pp 193-199 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A

Authors : Kosei Ishimaru; Masataka Ikeda; Hiroko Deguchi Miyamoto

Subjects: cyclosporin A; deferasirox; ferroptosis

Source: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 1 (2024)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Assessing the auditory effects of oral chelation therapy drug Deferasirox in individuals with β‐thalassemia major

PRT to predict pharmacokinetic profiles as part of a bioequivalence study of the drug deferasirox

Comparison of the effects of deferasirox film-coated tablets (Jadenu®) and deferasirox dispersible tablets (Exjade®) in patients with beta thalassemia major: a preliminary report of the effects on the satisfaction, convenience, cardiac/liver MRI T2*, serum ferritin level, and biochemical profiles

Deferasirox-induced hyperammonemia and Fanconi syndrome: a case report

Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics

Nanoparticle-Mediated Delivery of Deferasirox: A Promising Strategy Against Invasive Aspergillosis

Deferasirox in Patients with Chronic Kidney Disease: Assessing the Potential Benefits and Challenges

Deferasirox adherence in patients with thalassemia: Exploring the association with patient knowledge and ferritin levels

Switching from Deferasirox Dispersible Tablets to Deferasirox Film-Coated Tablets: Is There an Effect on Ferritin Levels in Children and Adolescents with Transfusion-Dependent Anemia?

Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A

اتصل بنا

اتبع